Clinical Trial Update: Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects [NA]

View source ↗

Summary

A clinical trial evaluating autologous platelet-rich plasma for the treatment of persistent epithelial defects is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Epithelial Defect

Drugs mentioned

• Autologous Platelet-Rich Plasma (platelet-rich plasma)

Snippet

Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: Persistent Epithelial Defect | NA | Status: RECRUITING